Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wojciech Majewski

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Contemporary Brachytherapy|March 2, 2022
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancerMarcin Miszczyk, Łukasz Magrowski, Oliwia Masri, et al.
Cancers|April 12, 2022
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate CancerMarcin Miszczyk, Justyna Rembak-Szynkiewicz, Łukasz Magrowski, et al.
Biomedicines|October 27, 2022
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological RiskMarcin Miszczyk, Monika Szołtysik, Maja Hasterok, et al.
Cancers|October 16, 2024
Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisAgata Suleja, Mateusz Bilski, Ekaterina Laukhtina, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 3, 2024
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boostMatthias Moll, Łukasz Magrowski, Martina Mittlböck, et al.
Biomedicines|October 27, 2022
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing RadiotherapyŁukasz Magrowski, Oliwia Masri, Jakub Ciepał, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2011
Progressive Cenozoic cooling and the demise of Antarctica's last refugiumJohn B Anderson, Sophie Warny, Rosemary A Askin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2023
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patientsMarcin Miszczyk, Łukasz Magrowski, Tomasz Krzysztofiak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2025
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)Giulio Francolini, Vanessa Di Cataldo, Saverio Caini, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Contemporary Brachytherapy|March 2, 2022
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancerMarcin Miszczyk, Łukasz Magrowski, Oliwia Masri, et al.
Cancers|April 12, 2022
The Prognostic Value of PI-RADS Score in CyberKnife Ultra-Hypofractionated Radiotherapy for Localized Prostate CancerMarcin Miszczyk, Justyna Rembak-Szynkiewicz, Łukasz Magrowski, et al.
Biomedicines|October 27, 2022
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological RiskMarcin Miszczyk, Monika Szołtysik, Maja Hasterok, et al.
Cancers|October 16, 2024
Stereotactic Body Radiotherapy (SBRT) for the Treatment of Primary Localized Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisAgata Suleja, Mateusz Bilski, Ekaterina Laukhtina, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 3, 2024
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boostMatthias Moll, Łukasz Magrowski, Martina Mittlböck, et al.
Biomedicines|October 27, 2022
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing RadiotherapyŁukasz Magrowski, Oliwia Masri, Jakub Ciepał, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2011
Progressive Cenozoic cooling and the demise of Antarctica's last refugiumJohn B Anderson, Sophie Warny, Rosemary A Askin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 24, 2023
Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patientsMarcin Miszczyk, Łukasz Magrowski, Tomasz Krzysztofiak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2025
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)Giulio Francolini, Vanessa Di Cataldo, Saverio Caini, et al.
Pageof 5